Scaling up the manufacture of syringes and other medical products required to deliver a vaccine to millions of Americans will be just as important as the vaccine itself ...
May 1, 2020
The New York Times – In the midst of national shortages of testing swabs and protective gear, some medical suppliers and health policy experts are looking ahead to another extraordinary demand on manufacturing: Delivering a vaccine that could potentially end the pandemic.
Making a vaccine...
Apr 17, 2020 |
CNN – Covid-19 patients who are getting an experimental drug called remdesivir have been recovering quickly, with most going home in days, STAT News reported Thursday after it obtained a video of a conversation about the trial.
The patients taking part in a clinical trial of the drug have all had severe respiratory symptoms and fever, but were able to leave the hospital after less than a week of treatment, STAT quoted...
"Tragic side effects" of taking drugs never meant for treating COVID-19
Guidance on patients at risk of drug-induced sudden cardiac death from off-label COVID-19 treatments
March 25, 2020
Mayo Clinic, Rochester, Minn. ― SARS-CoV-2, the virus that causes COVID-19, continues to spread, leading to more than 20,000 deaths worldwide in less than four months.
Efforts are progressing to develop a COVID-19 vaccine, but it's still likely 12 to 18 months away.
In the meantime, the pandemic, with over 400,000...
"It is a Band Aid ... We need reform of the system as whole."
State sends public employees to Mexico to bring back cheaper drugs |
SALT LAKE CITY (AP) — Ann Lovell had never owned a passport before last year.
Now, the 62-year-old teacher is a frequent flier, traveling every few months to Tijuana, Mexico, to buy medication for rheumatoid arthritis — with tickets paid for by the state of Utah's public insurer.
Lovell is one of...
“Drug corporations are ripping people off, and anyone who wants to compete with them deserves credit.” Ben Wakana, Patients for Affordable Drugs
Jan. 22, 2020
Los Angeles Times – A group of leading U.S. health insurers, frustrated by the high cost of prescription drugs, plan to start manufacturing versions of popular generic medications, hoping the competition with pharmaceutical companies will bring down costs.
The move — the latest salvo in the escalating battle to control drug prices...
Government control of healthcare has effectively removed supply-and-demand controls over drug pricing, meaning the sky is the limit on new rx costs. Here's how crony capitalist Big Pharma companies are cashing in ...
AXIOS – BioMarin Pharmaceutical is eyeing a $2-3 million price tag for its hemophilia gene therapy if it's approved, which could make it the world's most expensive drug, the Wall Street Journal reports.
Why it matters: It's a good reminder that today's pipeline...
Big Pharma insists on sending carcinogen-contaminated pills to the public
Jan 17, 2020
Salon – Big Pharma spends a small fortune every year buying politicians to make sure we can't import prescription drugs from Canada, but they're more than happy to sell us contaminated medications from countries with weak manufacturing controls and exploitable labor that ensure high profit margins.
A toxic compound that doesn't belong anywhere near medicine known as NDMA was first discovered in some blood...
"Patients are being prescribed pricey new medications that have not been tested as rigorously ... The large majority of newly approved drugs offer modest benefits over existing therapies."
Who needs testing when eager patients are waiting to pop the latest pill?
HealthDay News – New drugs are being approved by the U.S. Food and Drug Administration for patients based on less and less solid evidence, thanks to incentive programs that have been created to promote drug...
“This is a seminal moment for 23andMe”
Jan 10, 2020 |
For the first time, DNA testing company 23andMe has sold the rights to a new drug that it has developed using its customers’ data.
The deal, which is being investigated as a potential treatment for inflammatory diseases, is with Spanish pharmaceutical company Almirall.
“This is a seminal moment for 23andMe,” Emily Drabant Conley, 23AndMe’s vice-president of business development told Bloomberg. “We’ve now gone from database to discovery...
Jan 9, 2020
Ars Technica – A deadly fungal pathogen developed the ability to resist all existing antifungal drugs on three separate occasions in the United States, according to a new report.
The fungus, Candida auris, was already classified as an "urgent threat" by the Centers for Disease Control and Prevention. But the emergence of so-called "pan-resistant" strains raises additional concern, according to the report's authors, who are infectious disease specialists at the CDC and the...
Jan 9, 2020 |
Reuters – The U.S. Food and Drug Admin. approved Blueprint Medicines Corp’s oral therapy to treat a rare form of cancer that affects the stomach and small intestine, the agency said on Thursday.
The FDA’s decision makes the therapy, Ayvakit, the first treatment for a small subset of patients with a mutation of the cancer called gastrointestinal stromal tumor (GIST).
Blueprint said it expects to make Ayvakit available through a limited specialty pharmacy...
"Soon after he began the treatment, his wife began to notice a sinister transformation ... "
FDA approved meds that change who we are |
They’ve been linked to road rage, pathological gambling, and complicated acts of fraud. Some make us less neurotic, and others may even shape our social relationships. It turns out many ordinary medications don’t just affect our bodies – they affect our brains. Why? And should there be warnings on packets?
"Soaring U.S. prescription drug prices are expected to again be a central issue in the presidential election. " – REUTERS
Rx price increases are well above rate of inflation
Ars Technica – Leading drug makers rang in the new year by once again raising list prices of their drugs—this time on more than 250 of them, according to an analysis reported by Reuters.
Data examined by healthcare research firm 3 Axis Advisors found that major drug makers...
"The market has been plagued by shortages, often forcing people to switch their medications every couple of months."
Top 10 heart health findings of 2019
David Becker, Dec 31, 2019
Philadelphia Inquirer – There have been a number of major developments in the field of cardiology in 2019. Here is my list of the top 10 new findings that might affect your life:
1. Generic blood pressure drugs remain a big problem. When the generic drug for hypertension...
HEADLINE HEALTH • PO BOX 49043 • CHARLOTTE, NC 28277
THE INFORMATION PRESENTED HERE IS FOR GENERAL EDUCATIONAL PURPOSES ONLY. YOU SHOULD ALWAYS CONSULT WITH YOUR PERSONAL PHYSICIAN REGARDING ANY PERSONAL HEALTH PROBLEM, AND YOU SHOULD ALWAYS CONSULT WITH YOUR FINANCIAL ADVISER REGARDING INVESTMENT DECISIONS. FDA DISCLOSURE: THE STATEMENTS, ARTICLES, AND PRODUCTS FEATURED IN HEADLINE HEALTH EMAILS AND AT HEADLINEHEALTH.COM HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. NO INFORMATION OR PRODUCTS APPEARING IN EMAILS OR THE WEBSITE ARE INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE. MATERIAL CONNECTION DISCLOSURE: HEADLINE HEALTH MAY HAVE AN AFFILIATE RELATIONSHIP AND/OR ANOTHER MATERIAL CONNECTION TO ANY PERSONS OR BUSINESSES MENTIONED IN OR LINKED TO FROM EMAILS OR THE WEBSITE AND MAY RECEIVE COMMISSIONS FROM PURCHASES YOU MAKE ON SUBSEQUENT WEB SITES. YOU SHOULD NOT RELY SOLELY ON INFORMATION PUBLISHED BY HEADLINE HEALTH TO EVALUATE THE PRODUCT OR SERVICE BEING OFFERED. ALWAYS EXERCISE YOUR OWN DUE DILIGENCE BEFORE PURCHASING ANY PRODUCT OR SERVICE.